315 results on '"Tsankova, Nadejda"'
Search Results
2. Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma.
3. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma
4. In situ brain tumor detection using a Raman spectroscopy system—results of a multicenter study
5. Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors.
6. A phase I trial of VEGF-A inhibition combined with PD-L1 blockade for recurrent glioblastoma
7. Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign
8. Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma
9. P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas
10. U-Net Based Segmentation and Characterization of Gliomas
11. Multiparametric MRI Texture Analysis in Prediction of Glioma Biomarker Status: Added Value of MR Diffusion
12. A paracrine circuit of IL-1[beta]/IL-1R1 between myeloid and tumor cells drives genotype-dependent glioblastoma progression
13. Tumoral and immune heterogeneity in an anti-PD-1 responsive glioblastoma: a case study
14. MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting
15. A complete temporal transcription factor series in the fly visual system
16. Single-cell stabilization method identifies gonadotrope transcriptional dynamics and pituitary cell type heterogeneity
17. Chromosomal instability in adult-type diffuse gliomas
18. Correction: High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy
19. High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy
20. An atlas of late prenatal human neurodevelopment resolved by single-nucleus transcriptomics
21. Tumor immune microenvironment in brain metastases from gynecologic malignancies
22. Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway
23. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience
24. MODL-11. EXPLORING THE THERAPEUTIC POTENTIAL OF YAP-TEAD INHIBITORS FOR TARGETING GBM CELL MIGRATION AT THE INFILTRATIVE MARGIN
25. BIOM-35. IDENTIFICATION AND VALIDATION OF POTENTIAL BIOMARKERS FOR DECITABINE-MEDIATED SENSITIZATION TO TEMOZOLOMIDE IN GLIOBLASTOMA
26. ANGI-06. BIOLOGY OF GLIOBLASTOMA INVASION: A SINGLE-CELL LEVEL ANALYSIS OF TUMOR CORE VS. INFILTRATING EDGE
27. STEM-17. IMPLICATING ASTROCYTE PROGENITOR SIGNATURES FROM THE DEVELOPING HUMAN SUBVENTRICULAR ZONE IN GLIOBLASTOMA PROGRESSION AND RECURRENCE
28. Multi-omic profiling of the developing human cerebral cortex at the single-cell level
29. Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
30. Neuronal impact of patient-specific aberrant NRXN1α splicing
31. CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytoma
32. In Situ Brain Tumor Detection Using the Raman Spectroscopy Sentry System – Results of a Multicenter Study
33. R-loop landscapes in the developing human brain are linked to neural differentiation and cell-type specific transcription
34. The Prognostic Impact of Subclonal IDH1 Mutation in Grade 2-4 Astrocytomas
35. Suppl Fig FS3 from A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma
36. Table TS1 from A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma
37. Data from A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent Glioblastoma
38. A chromosomal connectome for psychiatric and metabolic risk variants in adult dopaminergic neurons
39. Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report
40. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors—A prospective study and guidelines for clinical testing
41. CDKN2Amutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytoma
42. Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma
43. Emerging Interplay of Genetics and Epigenetics in Gliomas: A New Hope for Targeted Therapy
44. EPCO-25. MULTI-OMIC ANALYSIS OF THE GLIOBLASTOMA EPIGENOME AND TRANSCRIPTOME INFORMS OF MIGRATORY INTERNEURON-LIKE DEVELOPMENTAL REGULATORS
45. IMMU-23. ELIMINATING MONOCYTE CHEMOATTRACTION INVOKES COMPENSATORY NEUTROPHIL INFLUX AND PRONEURAL TO MESENCHYMAL TRANSITION IN GLIOBLASTOMA
46. Multi-omic profiling of the developing human cerebral cortex at the single cell level
47. The novel compensatory reciprocal interplay between neutrophils and monocytes drives cancer progression
48. Molecular Tumor Board Case Report: IDH-mutant Astrocytoma with EGFR Amplification – Genomic Profiling in Four Cases and Review of Literature
49. A paracrine circuit of IL-1β/IL-1R1 between myeloid and tumor cells drives glioblastoma progression
50. Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.